21:20:28 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 41,027,425
Close 2024-04-24 C$ 0.145
Market Cap C$ 5,948,977
Recent Sedar Documents

Ndatalyze closes $150,000 (U.S.) private placement

2024-04-24 13:37 ET - News Release

Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) CLOSES ITS PREVIOUSLY-ANNOUNCED PRIVATE PLACEMENT

Ndatalyze Corp. has closed its previously announced private placement of one million common shares at 15 U.S. cents per share ($150,000 (U.S.)) to a single U.S. accredited investor. At a 1.375 exchange rate, this equates to approximately $206,250 and a subscription price of approximately 21 cents per share. A 6-per-cent finder's fee of $9,000 (U.S.) will be paid in cash to a third party and 90 per cent of the net proceeds will be allocated to the recently acquired Mindbalanced Inc. (MB) operations (Ndatalyze acquired 100 per cent of MB on April 16, 2024). The remainder will be used for general working capital. There are no warrants or rights attached to the shares and the shares will be subject to a minimum four-month hold period.

About Mindbalanced Inc.

Mindbalanced's vision is to redefine mental health care through an integrative, personalized approach leveraging cutting-edge technology and non-invasive treatment protocols. By harnessing evidence-based data, the company aims to predict and enhance mental well-being, taking into account individual predispositions and environmental factors, thereby fostering healthier and more fulfilling lives for all.

About YMI

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge toward a fuller understanding of how mental health develops and how to improve mental well-being. YMI combines supervised machine learning with a proprietary reference database to predict an individual's predisposition toward a variety of common mental conditions, both current and forward in time. YMI is poised to revolutionize mental health diagnoses while ensuring a sustainable revenue stream. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies and targeting key markets, YMI aligns both societal impact and financial success.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.